UGRO trades 2004.9% below Wall Street's consensus target of $81.25.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UGRO achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 30, 2026, urban-gro, Inc. (UGRO) has a Wall Street consensus price target of $81.25, based on estimates from 4 covering analysts. With the stock currently trading at $3.86, this represents a potential upside of +2004.9%. The company has a market capitalization of $2M.
Analyst price targets range from a low of $81.25 to a high of $81.25, representing a 0% spread in expectations. The median target of $81.25 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, UGRO trades at a trailing P/E of -0.1x. Analysts expect EPS to grow +91.3% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
GRWGGrowGeneration Corp. | $85M | $1.42 | $4.17 | +193.7% | Buy | — | 12 |
HYFMHydrofarm Holdings Group, Inc. | $4M | $0.81 | — | — | — | — | — |
LAURLaureate Education, Inc. | $5.2B | $36.36 | $39.00 | +7.3% | Buy | 17.1x | 11 |
IIPRInnovative Industrial Properties, Inc. | $1.8B | $63.26 | $84.67 | +33.8% | Hold | 14.8x | 11 |
SMGThe Scotts Miracle-Gro Company | $3.9B | $67.69 | $72.25 | +6.7% | Buy | 15.5x | 17 |
LWAYLifeway Foods, Inc. | $457M | $29.92 | $35.00 | +17.0% | Buy | 27.0x | 7 |
AMTXAemetis, Inc. | $115M | $1.69 | $1.75 | +3.6% | Buy | — | 7 |
WDFCWD-40 Company | $3.3B | $245.42 | $475.00 | +93.5% | Hold | 41.0x | 7 |
TROXTronox Holdings plc | $1.0B | $6.44 | $8.33 | +29.3% | Buy | — | 17 |
ACBAurora Cannabis Inc. | $178M | $2.88 | $5.92 | +105.6% | Hold | — | 14 |
Quick answers to the most common questions about buying UGRO stock.
The consensus Wall Street price target for UGRO is $81.25, representing 2004.9% upside from the current price of $3.86. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
UGRO has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $81.25 implies 2004.9% upside from current levels.
UGRO's current price is $3.86 with a consensus target of $81.25 (2004.9% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $81.25 for UGRO, while the most conservative target is $81.25. The consensus of $81.25 represents the median expectation. These targets typically reflect 12-month expectations.
UGRO is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UGRO stock forecast based on 4 Wall Street analysts shows a consensus price target of $81.25, with estimates ranging from $81.25 (bear case) to $81.25 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on UGRO, with a "Buy" consensus rating and $81.25 price target (2004.9% upside). 4 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UGRO analyst price targets range from $81.25 to $81.25, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $81.25 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.